CliffBio

Exelixis

Patent cliffs & loss of exclusivity

Small Molecules

Company

AngelList URLhttps://angel.co/exelixis-1
CAGE Code4GP15
Legal NameExelixis, Inc.
Company Operating StatusActive
Contact Page URLhttps://www.exelixis.com/contact-us/
Crunchbase URLhttps://www.crunchbase.com/organization/exelixis
Facebook URLhttps://www.facebook.com/exelixisinc/
Fax Number(650) 837-8300

5 upcoming patent cliffs

DrugIngredientTypeCliff
  1. COMETRIQCABOZANTINIB S-MALATESmall mol.Feb 2032
  2. COMETRIQCABOZANTINIB S-MALATESmall mol.Feb 2032
  3. CABOMETYXCABOZANTINIB S-MALATESmall mol.Jul 2033
  4. CABOMETYXCABOZANTINIB S-MALATESmall mol.Jul 2033
  5. CABOMETYXCABOZANTINIB S-MALATESmall mol.Jul 2033

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Exelixis — patent cliffs & loss of exclusivity | CliffBio